Healthcare and life sciences • Advisory
Independent clinical and scientific advice for health tech startups, AI labs, pharmaceutical companies and hospital systems. I am a consultant dermatologist and an Honorary Reader at King's College London, and I have published research on artificial intelligence in medicine since 2020.
Research published in
Clinical and scientific judgement at the points where healthcare AI most often goes wrong.
Founders building AI products for patients or clinicians.
Teams developing general or medical models.
Research, development and partnership teams.
Leaders deciding which AI tools to adopt and how.
Advisory work that gives your team a clear, independent clinical and scientific view.
Ongoing clinical and scientific advice to founders, boards and research teams as a product or programme develops.
You get: regular access to senior clinical and academic judgement.
Advice on how an AI system should be tested: which cases, which comparisons and which outcomes matter to patients, so that the evidence stands up to clinicians, buyers and reviewers.
You get: a written evaluation plan or a review of your existing evidence.
Identifying where an AI system could mislead clinicians or harm patients, drawing on my research into the vulnerabilities of deep learning for skin cancer diagnosis and the ethics of AI diagnosis.
You get: a clear account of the risks and how to reduce them.
Where an AI product fits into a real clinic, who acts on its output, what happens when it is wrong, and what clinicians and patients will trust.
You get: practical recommendations for the product and its clinical pathway.
An independent view of which AI tools are worth adopting, the evidence behind vendors' claims, and how to introduce and monitor them safely.
You get: an assessment and a practical plan.
Independent clinical and scientific review of an AI product, study or company, for partnerships, procurement or investment decisions.
You get: a written opinion you can act on.
Publications
I have written on artificial intelligence in medicine since 2020, from how deep learning works and where it fails in skin cancer diagnosis, to how large language models perform on specialist examinations and the ethics of AI diagnosis. My research group at King's College London also develops and tests its own skin cancer models.
British Journal of DermatologySole author
International Journal of Computer Assisted Radiology and Surgery
Contact DermatitisSenior author
Journal of Investigative DermatologySenior author
British Journal of DermatologySenior author
Try it yourself
My research group has put one of its skin lesion classifiers online so that anyone can see how this kind of AI behaves. It is a fine-tuned Inception v3 neural network, trained on 68,011 dermoscopic and clinical images from the ISIC Archive to recognise nine diagnostic groups.
The model downloads once and then runs entirely on your own device: your image is never uploaded. Choose a photograph of a single lesion or try one of the sample images, and the page shows how the network scores it.
It is a research demonstration, not a medical device, and it will miss skin cancers.
The same network is the baseline in my article A 10-year-old CNN outperforms frontier LLMs for skin cancer diagnosis, where it beat two frontier language models on 200 biopsy-proven lesions. The article went viral on Hacker News, with 670 points and 274 comments.
Advice that combines clinical experience, academic rigour and technical understanding.
Over twenty years in medicine, a consultant at St John's Institute of Dermatology, Guy's Hospital, and a busy private practice. I know which errors harm patients.
An Oxford doctorate, 50 publications and a research group at King's College London. I read evidence the way a journal reviewer does.
My research group trains and evaluates its own models, so I can engage in detail with your data scientists and engineers.
Years of explaining medicine on television and in the national press. I can explain an AI system's strengths and limits to a board, a clinical team or a patient.
From the clinic
I see patients every week at Guy's Hospital and in my private practice in Central London. That gives me a direct view of where AI can save clinicians time and help patients, and where it adds risk: errors that are hard to spot, extra steps in a crowded clinic, unclear responsibility when a tool is wrong, and the trust of patients.
My advice is about how AI works in real clinical care, not only how accurate it is on a test set.
We talk through what you are trying to achieve and whether I am the right person to help.
I set out the scope, what you will receive, the timeline and the fee.
Regular sessions or a defined review, depending on what you need.
A clear written summary of my findings and advice.
What organisations most often ask before we start.
Yes. I am based in London and most of the work is done remotely, so I can work with organisations anywhere.
Yes. I am happy to sign a confidentiality agreement before you share any details of your product or data.
My role is advisory. My research group develops and tests AI models, which keeps my advice technically grounded, and I work alongside your own data scientists and engineers.
I continue to see patients at Guy's Hospital and in private practice, which keeps my advice grounded in current clinical care. I take on a limited number of projects at a time so that each gets proper attention.
My clinical specialty is dermatology, where image-based AI is most advanced. The principles of clinical evaluation, safety and workflow apply across medicine, and I will say plainly when a question needs another specialist.
It depends on the scope. After an introductory call I send a written proposal with the fee.
Tell me briefly what you are working on. It helps to include:
Email contact@drmagnuslynch.com
I reply personally to every enquiry, usually within two working days.
Dr Magnus Lynch MA(Cantab) DPhil(Oxon) MRCS FRCP, Consultant Dermatologist and Honorary Reader at King's College London. See about Dr Lynch, research and publications.